Paper Title

Effect of Caryophyllene rich betel leaf extract on Triple Negative Breast Cancer cells: an in-silico and in-vitro approach

Article Identifiers

Registration ID: IJNRD_200362

Published ID: IJNRDTH00059

DOI: http://doi.one/10.1729/Journal.35004

Authors

Disha Mohanty , Kamaljit Nag , Luna Samanta

Keywords

β-Caryophyllene, CB2R, Triple Negative Breast Cancer, MTT, Live Dead Assay

Abstract

Triple-Negative Breast Cancer (TNBC) is a more advanced subtype of breast cancer that does not express the estrogen receptor, progesterone receptor and HER2/neu receptor. It is a kind of breast cancer which lacks all of those receptors that are commonly found in breast cancer. Because TNBC lacks the three receptors that are commonly targeted in breast cancer treatment, it can be more difficult to treat than other subtypes of breast cancer. This underscores the importance of investigating other factors that contribute to TNBC progression and developing novel therapies to target these factors. On the other hand, there is a growing body of research aimed at identifying new targets and therapies for TNBC. This ongoing research has been focused on the anticancer effects of Caryophyllene, which has been derived from the Piper betle leaf extracts. Caryophyllene, better known as β-caryophyllene, is a cannabis derived compound, which directly binds to cannabinoid receptors. These receptors have broadly been categorized into two receptors - Cannabinoid Receptor-1 (CB1R) and Cannabinoid Receptor-2 (CB2R). This study aims to identify the protein-ligand interaction between the CB2R and Caryophyllene, through an in-silico approach. It also aims to find the stimulating parameter between the protein and the ligand through an in-vitro approach on Piper betle leaves, which can detect the anticancer effects of Caryophyllene and its potent applications in TNBC treatment. For the in-silico work, a range of bioinformatics tools was utilized, such as PyMOL, AutoDockTools-1.5.7, and AutoDock Vina. Additionally, a few websites were utilized for compound screening, including PDB Database, Pubchem and UniprotKB. For the in-vitro research, two methods, which consisted of MTT Assay and Live Dead Assay, were notably used for analyzing Piper betle leaf extract. It was discovered that upon docking with the CB2R, the β-caryophyllene ligand does not form any polar hydrogen bonds with amino acid residues. It only engages in π-π stacking interactions with hydrophobic amino acid residues, particularly with phenylalanine. The MTT & Live Dead Assay was conducted using the MDA-MB-231 cell line, and the IC50 value was observed to be 0.3%. The compound β-caryophyllene drastically decreased the number of viable cells in the MDA-MB-231 cell line. These novel techniques identify the efficacy of Caryophyllene towards the prognosis and treatment of TNBC.

How To Cite (APA)

Disha Mohanty, Kamaljit Nag, & Luna Samanta (June-2023). Effect of Caryophyllene rich betel leaf extract on Triple Negative Breast Cancer cells: an in-silico and in-vitro approach. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 8(6), 738-794. http://doi.one/10.1729/Journal.35004

Citation

Issue

Volume 8 Issue 6, June-2023

Pages : 738-794

Other Publication Details

Paper Reg. ID: IJNRD_200362

Published Paper Id: IJNRDTH00059

Downloads: 000121992

Research Area: Biological Science

Country: Cuttack, Odisha, India

Published Paper PDF: https://ijnrd.org/papers/IJNRDTH00059.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRDTH00059

Crossref DOI: http://doi.one/10.1729/Journal.35004

About Publisher

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

Publication Timeline

Peer Review
Through Scholar9.com Platform

Article Preview: View Full Paper

Call For Paper

Call For Paper - Volume 10 | Issue 10 | October 2025

IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.

Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.

How to submit the paper?

Important Dates for Current issue

Paper Submission Open For: October 2025

Current Issue: Volume 10 | Issue 10 | October 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 31-Oct-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details